Security key
690469101
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 34,628,854
- Total 13F value
- $74,450,307
- Share change
- -501,962
- SEC-reported price per share
- $2.15
- Number of holders
- 52
- Value change
- -$3,009,412
- Number of buys
- 17
- Number of sells
- 38
- Shares outstanding
- 146,457,154
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
52
Top holders
10
OVID full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 690469101
Recent filing periods:
Ownership snapshot
Top reported holders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 4.7%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
4.7%
EcoR1 Capital, LLC
4.2%
Stonepine Capital Management, LLC
2.9%
VANGUARD GROUP INC
2.5%
Artal Group S.A.
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
4.7%
|
$21,512,000
6,851,051 shares
|
— | 31 Mar 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
4.2%
|
$19,209,000
6,117,400 shares
|
— | 31 Mar 2022 |
| Stonepine Capital Management, LLC |
13F
Company
|
2.9%
|
$13,245,000
4,218,069 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
2.5%
|
$11,580,000
3,687,909 shares
|
— | 31 Mar 2022 |
| Artal Group S.A. |
13F
Company
|
1.7%
|
$7,850,000
2,500,000 shares
|
— | 31 Mar 2022 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.5%
|
$6,715,000
2,139,290 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
52
Shares
34,628,854
Rows available
52
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
61
Q2 2022 holders
52
Holder diff
-9
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend